Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Semi-Equips - Buy when BLOOD is running in the streets! -- Ignore unavailable to you. Want to Upgrade?

To: Sam Citron who wrote (3216)	10/30/1997 9:18:00 PM
From: Elroy Jetson	Respond to of 10921

The relative safety in holding Cymer is that at the closing Bid of $24, the stock is more than 50% below its peak in August of ~$50. My small-cap biotech stocks are holding up even better. The investors in these companies are in for the long term. All of the hot money high-momentum stocks are getting creamed. You saw it even before the decline of the past seven days. Companies would come out with better than expected earnings and the stock would promptly drop as hi-mo investors bailed after not seeing an immeadiate run-up. I track Louis Navallier's 50 Blue Chip Stock letter picks as an example of a hi-mo portfolio. Since September 15 (6 weeks) the decline in his portfolio value is twice that of the S&P 500. Fortunately Cymer previously lost it's hi-mo investors during September. Elroy Jetson